NuVasive appoints Gregory T Lucier as chief executive officer


Gregory T Lucier has been appointed chief executive officer of NuVasive, effective immediately. Lucier, who has been serving as interim chief executive officer since 1 April, will continue as chairman of the NuVasive board of directors.

“Since being appointed interim chief executive officer, Greg has hit the ground running with an intense focus on driving NuVasive’s industry leadership,” said Jack R Blair, lead independent director of the NuVasive board. “As the board considered the needs of the company, we determined that this focus as well as Greg’s broad healthcare and leadership experience made him the right person to lead NuVasive forward. In addition to having a solid understanding of our strategy and business as a director, Greg brings a record of execution in areas that are also areas of strategic growth for NuVasive, including driving cutting-edge innovation, increased operational efficiencies and targeted expansion in key markets and geographies. With the support of our talented team of employee shareowners, we are confident that Greg will apply his skill set to the spine market to also drive compelling growth and value creation at NuVasive.”

Lucier said that he and the company “are committed to scaling our business and more efficiently deploying resources, rapidly growing our presence outside the USA and leading innovation in the spine market through the introduction of game-changing technologies such as our recently launched Integrated Global Alignment platform. We have a tremendous amount of opportunity ahead of us, and I am confident in our ability to accelerate our positive momentum and continue to generate value for our shareholders in 2015 and beyond.”